Emcure Pharmaceuticals has announced a massive 55% price cut for Poviztra, its semaglutide weight-management drug in India.
The Confederation of Indian Industry (CII) has petitioned the Department of Pharmaceuticals for freight subsidies and drug pricing relaxations as…
Pune-based startup CureMeAbroad is revolutionizing medical tourism with an AI-driven discovery platform for high-value patients from the US, UK, and…
While NATHEALTH reports a stable outlook for Indian hospitals amid the West Asia conflict, medical device manufacturers (AiMeD) are seeking…
While NATHEALTH leaders highlight a $1 trillion opportunity in raising India’s Health-Adjusted Life Expectancy (HALE), the industry must first navigate…
Following the patent expiry of semaglutide in India, leading pharma companies including Sun Pharma, Dr Reddy’s, Zydus, and Glenmark have…
Following the patent expiry of Novo Nordisk’s semaglutide on March 20, 2026, Indian drugmakers including Natco, Dr. Reddy’s, and Eris…
The Drugs Technical Advisory Board (DTAB) has deferred a proposal to mandate pharmaceutical companies to contribute 1% of profits to…
India’s private hospital sector is projected to maintain double-digit growth for the fifth year, with 15% revenue growth expected in…
The Drug Controller said that the focus is now on stricter quality, faster approvals and future-ready pharma regulation.
Novartis AG’s exit from its listed Indian subsidiary highlights a growing trend of “Big Pharma” companies divesting from the hyper-competitive…
Monthly treatment costs for popular weight-loss drugs like Ozempic and Wegovy are expected to plummet from ₹12,000 to nearly ₹3,000…
From TB to triage, AI redefines public health delivery
A study published in Lancet Regional Health warns that the HbA1c test may be unreliable for diagnosing and monitoring type-2…
‘Nutrition certainly plays an important role in a child’s overall development, but it is not the only factor that determines…
A groundbreaking multi-stakeholder report reveals that transitioning to Non-Animal Methods (NAMs) can reduce drug development costs by 90% and significantly…
Blockchain For Impact (BFI) and FITT-IIT Delhi have launched a specialized platform to accelerate AI healthtech startups.